Radar › Companies › Life Sciences · State of Sao Paulo
Radar · Life Sciences in State of Sao Paulo

Best Life Sciences Companies in State of Sao Paulo, Brazil

The 42 best Life Sciences companies in State of Sao Paulo, Brazil in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Open Health.

42companies tracked
$6.3Mdisclosed funding
0unicorns
7have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × STATE OF SAO PAULO

Our analysis of 576 Life Sciences companies

$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

576companies analysed
70%cloud-native stacks
2025funding peak (by rounds)
13unicorns
2016median founding year
82kcombined LinkedIn audience
71%of audience held by top 3
1companies hiring publicly (12 mo)

Ranked: Best Life Sciences companies in State of Sao Paulo

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackRecent signals
1Open Health
AI-powered platform to analyse laboratory results
$3M11 mo agoSeedGerrit Glass
Co-Founder
2022——
2Gen-t
Provider of gene bio-bank services to accelerate precision medicines
$2M34 mo agoSeedLygia Pereira
CEO
2021WordPressMySQLPHP+32—
3Ages Bioactive
Developer of nutritional products for the prevention and modulation of chronic diseases
$554K49 mo agoSeedAlejandro Espinola Bustamante
Co-Founder & Coo At Ages Bioactive Compounds
2019WordPressMySQLPHP+24—
4Ventrix
Developer of ECG devices for monitoring health and data management
$415K137 mo agoSeedRoberto Castro Junior
Founder
2005WordPressMySQLPHP+19—
5LizarBio Therapeutics
Developer of cell therapies for heart and neurological problems
$250K50 mo agoSeedMarcos Valadares
CEO
2013——
6Fix it
Provider of prostheses to improve arm mobility in individuals
$95K46 mo agoSeedHebert Costa
Co-Founder & CPO
2015WordPressMySQLPHP+29—
7Farmacocre
Developer of oral vaccine and DNA-based immune therapeutics for covid-19
—65 mo agoSeedHelena Lopes
Founder & CEO
2005——
8Pelenova
Developer of tissue regenerative medicine
—279 mo agoFunding RaisedJoaquim Coutinho
Co-Founder
1993——

Top 7 Life Sciences companies in State of Sao Paulo

#1
Seed · Sao Paulo, State of Sao Paulo · founded 2022
$3Mraised
▾

AI-powered platform to analyse laboratory results. It offer software for laboratories, nutritionists, and doctors that integrates and analyses all different types of laboratory exams and structures the data into a harmonized standard.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 3.0% of this cohort's audience
Funding rounds
  • Sep 2025Seed$3M
Founders & team
Gerrit GlassCo-Founder
Investors
GoHub, xdeck, EdenBase, Exceptional Ventures, YZR Capital, Octopus Ventures
#2
Seed · Sao Paulo, State of Sao Paulo · founded 2021
$1.9Mraised
▾

Provider of gene bio-bank services to accelerate precision medicines. It offers a platform for genetic biobank for genomic researcha to accelerate precision medicine and the development of medicines.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 4.4% of this cohort's audience
Activity: 1 partnerships · 1 awards (incl. Google Cloud) announced in 12 mo
Funding rounds
  • Oct 2023Seed—
  • Sep 2022Seed$1.9M
Founders & team
Lygia PereiraCEO
Investors
Roivant Sciences, Good Karma Partners
Tech stack
Apache Http ServerApolloBootstrapCdnjsCloudflareCloudflare Bot Management
#3
Seed · Sao Paulo, State of Sao Paulo · founded 2019 · 45 employees
$553.8Kraised
▾

Developer of nutritional products for the prevention and modulation of chronic diseases. The company focuses on the development of bioactive natural extracts that prevent and delay the aging process. The company's first product is a Phyto complex natural extract that acts on the musculoskeletal system to prevent and modulate major health problems such as osteopenia and osteoporosis, arthritis and arthrosis, myalgia, sarcopenia, and bone fragility, among others.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 7.2% of this cohort's audience
Activity: 3 awards announced in 12 mo
Funding rounds
  • Jul 2022Seed$553.8K
Founders & team
Alejandro Espinola BustamanteCo-Founder & Coo At Ages Bioactive Compounds
Investors
KPTL
Tech stack
AutoptimizeCloudflareCloudflare Browser InsightsGoogle AnalyticsGoogle Font ApiGoogle Tag Manager
#4
Seed · Sao Paulo, State of Sao Paulo · founded 2013 · 7 employees
$250Kraised
▾

Developer of cell therapies for heart and neurological problems. It offers cardiac-cell-based therapeutics for Heart Failure and astrocytes-based therapeutics for Rett Syndrome.

Funding rounds
  • Jul 2022Seed$250K
Founders & team
Marcos ValadaresCEO
Investors
IndieBio
#5
Seed · Sao Paulo, State of Sao Paulo · founded 2015 · 20 employees
$95.1Kraised
▾

Provider of prostheses to improve arm mobility in individuals. The platform is offering a 3D splint which is prepared by collecting your arm measurements. The orthosis is prepared using 3D printing technology. The orthosis made are eco-friendly.

Funding rounds
  • Nov 2022Seed$95.1K
Founders & team
Hebert CostaCo-Founder & CPO
Investors
GR8 Ventures, ACE Ventures
Tech stack
AosApache Http ServerBootstrapCart FunctionalityCloudflareCloudflare Bot Management
#6
Seed · Cotia, State of Sao Paulo · founded 2005 · 3 employees
$414.7Kraised
▾

Developer of ECG devices for monitoring health and data management. The company has developed Cardiofit (an ECG device that along with a telemedicine system performs ECG examinations remotely), Curavac (Vacuum dressing using negative pressure for the treatment of complex wounds), and Babyhug (a wearable device with a smartphone app that monitors baby's breathing and well-being).

Funding rounds
  • Mar 2015Seed$414.7K
Founders & team
Roberto Castro JuniorFounder
Investors
Criatec 2, SP Ventures, Crescera Capital, Triaxis Capital
Tech stack
Amazon Web ServicesBerqwpComplianzCore-JsDigitalocean SpacesElementor
#7
Seed · Ribeirao Preto, State of Sao Paulo · founded 2005
—raised
▾

Developer of oral vaccine and DNA-based immune therapeutics for covid-19. It has developed a Plasmid DNA-based immunomodulator for the prevention and treatment of infectious, autoimmune, and allergic diseases as well as tumors.

Funding rounds
  • Mar 2021Seed—
Founders & team
Helena LopesFounder & CEO

Funding & investor landscape

$6.3Mtotal disclosed funding
6companies funded
6disclosed rounds
0rounds last 90 days
Most active investors
ACE Ventures1 rounds
Biominas1 rounds
Calm/Storm1 rounds
Crescera Capital1 rounds
Criatec 21 rounds
DGF1 rounds
EdenBase1 rounds
Exceptional Ventures1 rounds
GR8 Ventures1 rounds
GoHub1 rounds

Notable founders

Gerrit Glass
Co-Founder · Open Health
Lygia Pereira
CEO · Gen-t
Alejandro Espinola Bustamante
Co-Founder & Coo At Ages Bioactive Compounds · Ages Bioactive
Marcos Valadares
CEO · LizarBio Therapeutics
Hebert Costa
Co-Founder & CPO · Fix it
Roberto Castro Junior
Founder · Ventrix
Helena Lopes
Founder & CEO · Farmacocre
Prism market signals · Brazil · country-scoped Prism corpus, 1,505,248 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Brazil

How research on Biotechnology is moving in Brazil

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,470 Brazil-affiliated papers.

research sentiment over time
201020172026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and softening — the enthusiastic (strongly-positive) share moved 68% → 54% across 2010–2026.
top research entities
  • Universidade de São Paulo120
  • Universidade Estadual de Campinas113
  • Universidade Estadual Paulista85
  • Ministry of Education70
  • Brazilian Agricultural Research Corporation64
leading researchers
Rayanna Barroso de Oliveira Alves · Diego Bogado Tomasiello · Claudia Maria De Almeida · David Luciano Rosalen · Luiz Henrique Pereira · Lucas dos Santos Sa · Carlos Camacho · Denecir De Almeida Dutra
▲ Breakthroughs121 · 8%
▲ 0%→8% share
0 median citations98% since 2021mostly methods-led
Breakthroughs are rising (0%→8% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene9
  • Genome7
  • Metabolomics7
  • Production (economics)6
  • Livestock5
Newly emergingGene 0→9 · Genome 0→7 · Metabolomics 0→7
Landmark Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles · 540 cites
◆ Advancements651 · 44%
▼ 47%→44% share
▼0.9× share momentum0 median citations95% since 2021mostly empirical
Advancements are cooling (47%→44% of field), led by Context (archaeology).
rising sub-themes (early→recent)
  • Context (archaeology)2→47
  • Fermentation2→36
  • Antimicrobial3→34
  • Bacteria1→17
  • Biomass (ecology)1→17
Newly emergingGene 0→25 · Agriculture 0→22 · In vitro 0→19
Landmark Male Sterility and Fertility Restoration in Crops · 946 cites
▼ Concerns357 · 24%
▲ 8%→25% share
▲3.1× share momentum0 median citations97% since 2021mostly empirical
Concerns are rising (8%→25% of field), led by Biofuel.
rising sub-themes (early→recent)
  • Biofuel1→5
  • Fermentation1→5
  • In vitro1→4
Newly emergingContext (archaeology) 0→34 · Agriculture 0→16 · Animal model 0→16
Landmark Effects of textile dyes on health and the environment and bioremediation potential of living organisms · 2,588 cites
RESEARCH HOTSPOTS · Brazil

Where biotechnology is researched across Brazil

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

São Paulo242 · +0.30
Hot · Complementary DNAAdvancing · BiofuelOpportunity · BacteriaConcern · Biomass (ecology)
Brasília199 · +0.45
Hot · Messenger RNAAdvancing · DNA methylationOpportunity · TranscriptomeConcern · Resistance (ecology)
Campinas120 · +0.26
Hot · Qualitative analysisAdvancing · GenomeOpportunity · Gene
Rio de Janeiro85 · +0.22
Hot · Insecticide resistanceAdvancing · CancerOpportunity · Gene
Curitiba70 · +0.17
Hot · FermentationAdvancing · ProbioticOpportunity · AntimicrobialConcern · Sustainability
Recife65 · +0.13
Hot · Beauveria bassianaOpportunity · PopulationConcern · Animal model
Belo Horizonte55 · +0.22
Hot · Escherichia coliAdvancing · AntibodyOpportunity · Antibiotic resistance
Florianópolis55 · +0.14
Hot · AquacultureAdvancing · AntimicrobialOpportunity · CropConcern · Sustainability
Porto Alegre38 · +0.34
Hot · FermentationAdvancing · Sensory analysisOpportunity · Gene expression
Salvador26 · +0.22
Advancing · Yield (engineering)Opportunity · Fermentation

Common questions

How many Life Sciences companies are there in State of Sao Paulo, Brazil?
Radar tracks 42 indexable Life Sciences companies headquartered in State of Sao Paulo, Brazil that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in State of Sao Paulo, Brazil?
The Life Sciences companies in State of Sao Paulo, Brazil on this list have raised a combined $6.3M in disclosed equity funding across 6 funded companies.
Which is the highest-funded Life Sciences company in State of Sao Paulo, Brazil?
Open Health is the highest-funded Life Sciences company in State of Sao Paulo, Brazil, with $3M in disclosed equity funding.
How many Life Sciences companies in State of Sao Paulo, Brazil are funded?
6 of the 42 Life Sciences companies in State of Sao Paulo, Brazil on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in State of Sao Paulo, Brazil?
None of the Life Sciences companies in State of Sao Paulo, Brazil on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in State of Sao Paulo, Brazil Life Sciences companies?
The most active investors in State of Sao Paulo, Brazil Life Sciences companies on this list include ACE Ventures, Biominas, Calm/Storm, Crescera Capital, Criatec 2.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon